These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3435984)

  • 1. 5-Fluorouracil derivatives. XII. Synthesis and antitumor activity of alpha-alkylthiomethyl-, alpha-alkylsulfinylmethyl-, alpha-alkylsulfonylmethyl-, and alpha-acylthiomethyl-5-fluorouracils.
    Ozaki S; Nagase T; Tamai H; Mori H; Hoshi A; Iigo M
    Chem Pharm Bull (Tokyo); 1987 Sep; 35(9):3894-7. PubMed ID: 3435984
    [No Abstract]   [Full Text] [Related]  

  • 2. 5-Fluorouracil derivatives. X. Synthesis and antitumor activities of alpha-alkoxyalkyl-5-fluorouracils.
    Ozaki S; Watanabe Y; Hoshiko T; Nagase T; Ogasawara T; Furukawa H; Uemura A; Ishikawa K; Mori H; Hoshi A
    Chem Pharm Bull (Tokyo); 1986 Jan; 34(1):150-7. PubMed ID: 3698125
    [No Abstract]   [Full Text] [Related]  

  • 3. 5-Fluorouracil derivatives. XXII. Synthesis and antitumor activities of 1-carbamoyl-5-fluorouracils.
    Ozaki S; Kong X; Watanabe Y; Hoshiko T; Koga T; Ogasawara T; Takizawa T; Fujisawa H; Iigo M; Hoshi A
    Chem Pharm Bull (Tokyo); 1997 Aug; 45(8):1372-5. PubMed ID: 9301037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A facile method for synthesis of N-acyloxymethyl-5-fluorouracils, as a class of antitumor agents.
    Ahmad S; Ozaki S; Nagase T; Iigo M; Tokuzen R; Hoshi A
    Chem Pharm Bull (Tokyo); 1987 Oct; 35(10):4137-43. PubMed ID: 3435940
    [No Abstract]   [Full Text] [Related]  

  • 5. 5-Fluorouracil derivatives. IX. Synthesis and antitumor activities of (alkylthio)carbonyl-5-fluorouracils.
    Hoshiko T; Ozaki S; Watanabe Y; Ogasawara T; Yamauchi S; Fujiwara K; Hoshi A; Iigo M
    Chem Pharm Bull (Tokyo); 1985 Jul; 33(7):2832-7. PubMed ID: 4085042
    [No Abstract]   [Full Text] [Related]  

  • 6. N-Alkylated derivatives of 5-fluorouracil.
    Kundu NG; Schmitz SA
    J Pharm Sci; 1982 Aug; 71(8):935-8. PubMed ID: 7120102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antitumor activity of 1- or 3-(alpha-hetero substituted)alkyl-5-fluorouracil derivatives.
    Ozaki S; Nagase T; Ahmad S; Tamai H; Hoshi A; Iigo M
    Nucleic Acids Symp Ser; 1987; (18):1-4. PubMed ID: 3697106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of 1-acyloxymethyl derivatives of 5-fluorouracil against L1210 leukemia.
    Hoshi A; Inomata M; Kanzawa F; Iigo M; Kuretani K
    J Pharmacobiodyn; 1982 Mar; 5(3):208-12. PubMed ID: 7097489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Fluorouracil derivatives. IV. Synthesis of antitumor-active acyloxyalkyl-5-fluorouracils.
    Ozaki S; Watanabe Y; Hoshiko T; Mizuno H; Ishikawa K; Mori H
    Chem Pharm Bull (Tokyo); 1984 Feb; 32(2):733-8. PubMed ID: 6733816
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the synthesis of chemotherapeutics. 12. Synthesis and antitumor activity of N-phthalidyl-5-fluorouracil derivatives.
    Kametani T; Kigasawa K; Hiiragi M; Wakisaka K; Nakazato K; Ichikawa K; Fukawa K; Irino O; Nishimura N; Okada T
    J Med Chem; 1982 Oct; 25(10):1219-22. PubMed ID: 7143359
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis and in vivo antitumor activity of potential 5-fluorouracil prodrugs.
    Rosowsky A; Kim SH; Trites D; Wick M
    J Med Chem; 1982 Sep; 25(9):1034-40. PubMed ID: 7131481
    [No Abstract]   [Full Text] [Related]  

  • 12. 5-Fluorouracil derivative. XVII. Synthesis and antitumor activity of 5'-O-acyl-5-fluorouridines.
    Ozaki S; Akiyama T; Ike Y; Mori H; Hoshi A
    Chem Pharm Bull (Tokyo); 1989 Dec; 37(12):3405-8. PubMed ID: 2632088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antitumor activity of 5-fluorouracil derivatives.
    Ozaki S
    Med Res Rev; 1996 Jan; 16(1):51-86. PubMed ID: 8788214
    [No Abstract]   [Full Text] [Related]  

  • 14. 5-Fluorouracil derivatives. XX. Synthesis and antitumor activity of 5'-O-unsaturated acyl-5-fluorouridines.
    Ozaki S; Akiyama T; Morita T; Kumegawa M; Nagase T; Uehara N; Hoshi A
    Chem Pharm Bull (Tokyo); 1990 Nov; 38(11):3164-6. PubMed ID: 2085902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antitumor activity of 5-fluoro-4-(furfurylideneaminooxy)hexahydro-2,6-dioxo-5-pyrim idinecarb oxylates.
    Okutani T; Ukawa K; Yamamoto H; Amano T; Nomura H; Ootsu K; Kozai Y
    Chem Pharm Bull (Tokyo); 1986 Feb; 34(2):713-9. PubMed ID: 3708727
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthesis and activities of antitumor agents.
    Suami T; Machinami T; Hisamatsu T
    J Med Chem; 1979 Mar; 22(3):247-50. PubMed ID: 423206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the synthesis of chemotherapeutics. 10. Synthesis and antitumor activity of N-acyl- and N-(alkoxycarbonyl)-5-fluorouracil derivatives.
    Kametani T; Kigasawa K; Hiiragi M; Wakisaka K; Haga S; Nagamatsu Y; Sugi H; Fukawa K; Irino O; Yamamoto T; Nishimura N; Taguchi A; Okada T; Nakayama M
    J Med Chem; 1980 Dec; 23(12):1324-9. PubMed ID: 7452684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of Pt(II) complexes containing diaminocarboxylates and their ester derivatives.
    Noji M; Hanamura S; Suzuki K; Tashiro T; Kidani Y
    Chem Pharm Bull (Tokyo); 1986 Jun; 34(6):2487-93. PubMed ID: 3769066
    [No Abstract]   [Full Text] [Related]  

  • 19. Syntheses and biological activities of N1-(2-formylethyl)-5-fluorouracil and related compounds.
    Kawase M; Samejima K; Okada M; Ochi K; Matsunaga I
    Chem Pharm Bull (Tokyo); 1985 Jun; 33(6):2395-402. PubMed ID: 4064198
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on antitumor agents. V. Syntheses and antitumor activities of 5-fluorouracil derivatives.
    Yamashita J; Yamawaki I; Ueda S; Yasumoto M; Unemi N; Hashimoto S
    Chem Pharm Bull (Tokyo); 1982 Dec; 30(12):4258-67. PubMed ID: 7168864
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.